Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4243009
Max Phase: Preclinical
Molecular Formula: C69H91N15O15
Molecular Weight: 1370.58
Molecule Type: Small molecule
Associated Items:
ID: ALA4243009
Max Phase: Preclinical
Molecular Formula: C69H91N15O15
Molecular Weight: 1370.58
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC[C@H](C)[C@H](NC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(=O)O)C(=O)O
Standard InChI: InChI=1S/C69H91N15O15/c1-5-40(4)58(83-59(89)48(70)35-45-37-73-38-75-45)67(97)84-29-13-19-56(84)66(96)76-49(18-12-28-74-69(71)72)60(90)78-51(31-41-14-8-6-9-15-41)63(93)80-53(33-43-20-24-46(85)25-21-43)62(92)77-50(30-39(2)3)61(91)79-52(32-42-16-10-7-11-17-42)64(94)81-54(34-44-22-26-47(86)27-23-44)65(95)82-55(68(98)99)36-57(87)88/h6-11,14-17,20-27,37-40,48-56,58,85-86H,5,12-13,18-19,28-36,70H2,1-4H3,(H,73,75)(H,76,96)(H,77,92)(H,78,90)(H,79,91)(H,80,93)(H,81,94)(H,82,95)(H,83,89)(H,87,88)(H,98,99)(H4,71,72,74)/t40-,48-,49-,50-,51-,52-,53-,54-,55-,56-,58-/m0/s1
Standard InChI Key: PXSRBAFJNWPMBY-JUVBYKDMSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1370.58 | Molecular Weight (Monoisotopic): 1369.6819 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Ebner S, Trieb M, Schönfeld M, Wietzorrek G, Santos-Sierra S.. (2018) Decoy peptides derived from the extracellular domain of toll-like receptor 2 (TLR2) show anti-inflammatory properties., 26 (16): [PMID:30093346] [10.1016/j.bmc.2018.07.013] |
Source(1):